Risk Factors for Extrapyramidal Symptoms During Treatment With Selective Serotonin Reuptake Inhibitors, Including Cytochrome P-450 Enzyme, and Serotonin and Dopamine Transporter and Receptor Polymorphisms-Reference-Cited by-同舟云学术

Risk Factors for Extrapyramidal Symptoms During Treatment With Selective Serotonin Reuptake Inhibitors, Including Cytochrome P-450 Enzyme, and Serotonin and Dopamine Transporter and Receptor Polymorphisms

Published:2006-04 Issue:2 Volume:26 Page:192-197
ISSN:0271-0749
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:

Author:

Hedenmalm Karin,Güzey Cüneyt,Dahl Marja-Liisa,Yue Qun-Ying,Spigset Olav

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference44 articles.

1. Extrapyramidal symptoms with selective serotonin reuptake inhibitors.;Arya;Br J Psychiatry,1994

2. Movement disorders associated with the serotonin selective reuptake inhibitors.;Leo;J Clin Psychiatry,1996

3. "Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review.;Damsa;J Clin Psychiatry,2004

4. Existing brain condition may predispose to SSRI-induced extrapyramidal symptoms.;Arya;Aust N Z J Psychiatry,1997

5. SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment.;Lane;J Psychopharmacol,1998

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sertraline-Induced Galactorrhoea: A Case Report;Cureus;2024-06-14

2. From Evidence to Practice: A Comprehensive Analysis of Side Effects in Synthetic Anti-Depressant Therapy;Current Drug Safety;2024-04-25

3. Prevalence and causative drugs of drug-induced Parkinsonism in pediatric patients;European Child & Adolescent Psychiatry;2023-04-11

4. Acute Dystonia After Low-Dose Sertraline Treatment;Journal of Clinical Psychopharmacology;2023-01

5. Therapy of recurrent depressive disorders taking into account hereditary, pharmacogenetic, and social factors.;19;2022-08-30